Utama › Penyakit Paru-paru
Kajian klinikal Penyakit Paru-paru sedang mengambil peserta di AS
57 kajian untuk Penyakit Paru-paru sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX15 kajian
- Boston, MA14 kajian
- Durham, NC13 kajian
- New York City, NY12 kajian
- Pittsburgh, PA11 kajian
- Nashville, TN10 kajian
- Columbus, OH10 kajian
- Los Angeles, CA10 kajian
- Dallas, TX10 kajian
- Washington, DC10 kajian
- Miami, FL10 kajian
- Ann Arbor, MI10 kajian
- Chicago, IL9 kajian
- Birmingham, AL9 kajian
- Orlando, FL8 kajian
- Baltimore, MD8 kajian
- Philadelphia, PA8 kajian
- Cincinnati, OH7 kajian
- Atlanta, GA7 kajian
- Tampa, FL7 kajian
- Detroit, MI7 kajian
- Jacksonville, FL7 kajian
- Charleston, SC7 kajian
- Seattle, WA7 kajian
- Salt Lake City, UT6 kajian
- St. Louis, MO6 kajian
- Kansas City, KS6 kajian
- Portland, OR5 kajian
- Arlington, VA5 kajian
- Louisville, KY5 kajian
- Hialeah, FL5 kajian
- San Francisco, CA5 kajian
- Winston-Salem, NC5 kajian
- Oklahoma City, OK5 kajian
- Indianapolis, IN5 kajian
- Richmond, VA4 kajian
- Cleveland, OH4 kajian
- Orange, CA4 kajian
- Charlotte, NC4 kajian
- Kansas City, MO4 kajian
Mengikut negeri
- Alabama13 kajian
- Arizona9 kajian
- California30 kajian
- Colorado12 kajian
- Florida26 kajian
- Georgia11 kajian
- Hawaii3 kajian
- Idaho3 kajian
- Illinois16 kajian
- Indiana5 kajian
- Kansas9 kajian
- Kentucky9 kajian
- Louisiana5 kajian
- Maryland13 kajian
- Massachusetts15 kajian
- Michigan17 kajian
- Minnesota7 kajian
- Missouri8 kajian
- Nebraska4 kajian
- Nevada6 kajian
- New Jersey6 kajian
- New Mexico3 kajian
- New York16 kajian
- North Carolina18 kajian
- Ohio18 kajian
- Oklahoma5 kajian
- Oregon5 kajian
- Pennsylvania21 kajian
- Rhode Island4 kajian
- South Carolina11 kajian
- Tennessee15 kajian
- Texas22 kajian
- Utah7 kajian
- Vermont4 kajian
- Virginia10 kajian
- Washington8 kajian
- Wilayah Columbia6 kajian
- Wisconsin3 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Study of the Disease Process of Lymphangioleiomyomatosis
Mengambil pesertaKajian pemerhatian
Umur 16 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT00001465Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01730092Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06765109A Study of COVID-19 Vaccine(s) in Children and Adults
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
Umur 5 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07489066A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Mengambil pesertaFasa 2
Umur 40 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07759245American Lung Association (ALA) Lung Health Cohort
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 25 hingga 35 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT04543461Study of Lung Proteins in Patients With Pneumonia
Mengambil pesertaKajian pemerhatian
Umur 3 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT00077909Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06977581A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07407933Role of Genetic Factors in the Development of Lung Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 hingga 90 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT00001532A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06572384A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07059091Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Mengambil pesertaFasa 2
Umur 18 hingga 85 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07333183A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT05967689A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
Mengambil pesertaFasa 2
Umur 4 hingga 11 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07525375A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 60 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07745907Understanding New Cachexia Subtypes Through Observational Epidemiological Research
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07776353A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT07555483Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.